CVAC
Price:
$4.66
Market Cap:
$903.24M
CureVac N.V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vaccines. Among these is CV2CoV, an mRNA vaccine candidate addressing SARS-CoV-2, presently in Phase 1 clinical investigation. Another key candidate, CV7202, an mRNA prophylactic targeting the rabies virus glycoprotein, has successfully completed its Phase 1 clinical evaluation. Additionally, CVSQIV, aimed at influenza, is also undergoing Phase 1 clinical trials. Further vaccine development efforts are directed towards lassa fever, yellow fever, res...[Read more]
Industry
Biotechnology
IPO Date
2020-08-14
Stock Exchange
NASDAQ
Ticker
CVAC
According to CureVac N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 522.22M. This represents a change of 15.72% compared to the average of 451.30M of the last 4 quarters.
The mean historical Enterprise Value of CureVac N.V. over the last ten years is 4.52B. The current 522.22M Enterprise Value has changed 1.06% with respect to the historical average. Over the past ten years (40 quarters), CVAC's Enterprise Value was at its highest in in the March 2021 quarter at 15.67B. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.
Average
4.52B
Median
4.83B
Minimum
296.10M
Maximum
9.37B
Discovering the peaks and valleys of CureVac N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 9.46%
Maximum Annual Enterprise Value = 9.37B
Minimum Annual Increase = -87.35%
Minimum Annual Enterprise Value = 296.10M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 296.10M | -38.20% |
| 2023 | 479.14M | -21.59% |
| 2022 | 611.05M | -87.35% |
| 2021 | 4.83B | -35.40% |
| 2020 | 7.48B | -20.17% |
| 2019 | 9.37B | 9.46% |
The current Enterprise Value of CureVac N.V. (CVAC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
462.09M
5-year avg
2.74B
10-year avg
4.52B
CureVac N.V.’s Enterprise Value is less than Novavax, Inc. (1.53B), less than Nektar Therapeutics (1.17B), less than Syndax Pharmaceuticals, Inc. (1.83B), less than Inhibrx Biosciences, Inc. (1.20B), less than Amylyx Pharmaceuticals, Inc. (989.29M), less than Immatics N.V. (796.19M), less than Relay Therapeutics, Inc. (2.42B), less than ORIC Pharmaceuticals, Inc. (799.69M), less than Enliven Therapeutics, Inc. (2.68B), less than Tourmaline Bio, Inc. (1.20B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.53B | $1.46B | |
| 1.17B | $1.16B | |
| 1.83B | $1.62B | |
| 1.20B | $1.35B | |
| 989.29M | $1.21B | |
| 796.19M | $1.26B | |
| 2.42B | $2.59B | |
| 799.69M | $856.09M | |
| 2.68B | $2.81B | |
| 1.20B | $1.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CureVac N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CureVac N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CureVac N.V.'s Enterprise Value?
What is the highest Enterprise Value for CureVac N.V. (CVAC)?
What is the 3-year average Enterprise Value for CureVac N.V. (CVAC)?
What is the 5-year average Enterprise Value for CureVac N.V. (CVAC)?
How does the current Enterprise Value for CureVac N.V. (CVAC) compare to its historical average?